Cargando…
Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancer
PURPOSE: In pediatric patients with differentiated thyroid cancer (DTC) we assessed the prognostic value of the 12-month response to therapy after initial treatment with surgery and radioactive iodine (RAI). METHODS: We retrospectively evaluated 94 pediatric patients with DTC, treated with surgery a...
Autores principales: | Zampella, Emilia, Piscopo, Leandra, Manganelli, Mariarosaria, Volpe, Fabio, Nappi, Carmela, Gaudieri, Valeria, Pace, Leonardo, Schlumberger, Martin, Cuocolo, Alberto, Klain, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199830/ https://www.ncbi.nlm.nih.gov/pubmed/36692657 http://dx.doi.org/10.1007/s12020-023-03309-7 |
Ejemplares similares
-
Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021) -
Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis
por: Piscopo, Leandra, et al.
Publicado: (2023) -
Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study
por: Piscopo, Leandra, et al.
Publicado: (2022) -
Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: a systematic review and a meta-analysis
por: Klain, Michele, et al.
Publicado: (2021) -
Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021)